With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
GEN,
Absci CEO Sean McClain Absci says it is about a year away from its lead AI-designed therapeutic entering the clinic—one of…
Absci CEO Sean McClain Absci says it is about a year away from its lead AI-designed therapeutic entering the clinic—one of…
Pictured: A person with an irritated gut/Taylor Tieden for BioSpace Twenty-two years ago, a molecule called TL1A was first…
Summary Merck's business has been dominated by its oncology drug Keytruda and HPV vaccine Gardasil, which have sustained its…
Pictured: Sanofi headquarters/iStock, HJBC In a potential challenge to Merck and Pfizer, French drugmaker Sanofi announced…